Stocktoria

Bioquest Corp BQST

OTC · stock · Pharmaceutical Preparations · website · IPO 2013-09-26

Bioquest Corp financials (annual, from 10-K)

Revenue
201320132013201420142014202020212022
Net income
201320132013201420142014202020212022
Free cash flow
201320132013201420142014202020212022

Bars are annual figures from 2013 to 2022; red bars are negative (a loss or cash outflow).

MetricFY2022FY2021FY2020FY2014FY2014FY2014FY2013FY2013FY2013
Revenue$0$0$0$0$0
Operating income-$817,920-$2.2M-$356,554-$123,709-$19,958-$18,795-$15,541-$8,277
Interest expense$37,638$2,475
Income tax$0$0
Net income-$821,022-$2.3M-$359,029-$3.4M-$487,992-$18,508-$18,795-$15,541-$8,277
Operating cash flow-$116,720-$193,206-$124,834-$472,076-$17,213-$17,661-$14,569-$7,629
Free cash flow-$15,257-$15,705
Cash & equivalents$33,540$260$166$848,036$543,853$452$4$3,096$7,978
Inventory$0$0
Total assets$33,540$17,097$166$5.2M$889,903$1,112$826$4,080$9,124
Total liabilities$466,530$1.8M$138,745$381,340$14,700$101$101$101
Shareholders' equity-$432,990-$1.8M-$138,579$4.8M$875,203$1,011$725$3,979$9,023

Source: SEC EDGAR filings · CIK 0001568628 · US · as of 2022-04-30. facts plus Stocktoria's own computed scores — not investment advice.